All lobbying filings
ARNOLD & PORTER KAYE SCHOLER LLP
Lobbying for RECORDATI RARE DISEASES INC. · Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.
Filing
Registration
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Nov 14, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Lobbyists on this filing
4
-
BOBBY MCMILLIN New on this filingPreviously held: General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)
-
PETER ERIC DUYSHART New on this filingPreviously held: Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015)
-
VICTORIA DAVILA New on this filingPreviously held: Intern, Rep. Pramila Jayapal (2024)
-
EUGENIA PIERSON New on this filingPreviously held: Clerk, House Energy and Commerce Committee (2001-05)
Lobbying activity
3
Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.
Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.
Issues related to improving access to needed therapies for rare and ultra-rare diseases in the U.S.
Foreign interests disclosed
1
-
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.Italy · Milan · owns 100% of the client · contributed $0.00